1 |
Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002;46:S63-97.
DOI
ScienceOn
|
2 |
Marneros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol 2001;137:1429-34.
DOI
ScienceOn
|
3 |
LeFlore IC. Misconceptions regarding elective plastic surgery in the black patient. J Natl Med Assoc 1980;72:947-8.
|
4 |
Alhady SM, Sivanantharajah K. Keloids in various races: a review of 175 cases. Plast Reconstr Surg 1969;44:564-6.
DOI
ScienceOn
|
5 |
Bayat A, Arscott G, Ollier WE, et al. "Aggressive keloid": a severe variant of familial keloid scarring. J R Soc Med 2003; 96:554-5.
DOI
ScienceOn
|
6 |
Marneros AG, Norris JE, Watanabe S, et al. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol 2004;122:1126-32.
DOI
ScienceOn
|
7 |
Chen Y, Gao JH, Liu XJ, et al. Characteristics of occurrence for Han Chinese familial keloids. Burns 2006;32:1052-9.
DOI
ScienceOn
|
8 |
Bella H, Heise M, Yagi KI, et al. A clinical characterization of familial keloid disease in unique African tribes reveals distinct keloid phenotypes. Plast Reconstr Surg 2011;127:689-702.
DOI
ScienceOn
|
9 |
Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974;53:276-80.
DOI
ScienceOn
|
10 |
Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975;67:428-32.
|
11 |
Kelly AP. Keloids. Dermatol Clin 1988;6:413-24.
|
12 |
Child FJ, Fuller LC, Higgins EM, et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 1999;141:512-7.
DOI
ScienceOn
|
13 |
Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther 2004;17:212-8.
DOI
ScienceOn
|
14 |
Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res 2010;302:319-39.
DOI
ScienceOn
|
15 |
Fujiwara M, Muragaki Y, Ooshima A. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Arch Dermatol Res 2005;297:161-9.
DOI
ScienceOn
|
16 |
Gao Z, Wang Z, Shi Y, et al. Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA. Plast Reconstr Surg 2006;118:1328-37.
DOI
ScienceOn
|
17 |
Wang Z, Gao Z, Shi Y, et al. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg 2007;60:1193-9.
DOI
ScienceOn
|
18 |
Chen Y, Gao JH, Liu XJ, et al. Linkage analysis of keloid susceptibility loci on chromosome 7p11 in a Chinese pedigree. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:623-5.
|
19 |
Yan X, Gao JH, Chen Y, et al. Preliminary linkage analysis and mapping of keloid susceptibility locus in a Chinese pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23: 32-5.
|
20 |
Chen Y, Gao JH, Yan X, et al. Location of predisposing gene for one Han Chinese keloid pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23:137-40.
|
21 |
Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and transforming growth factor beta 2 polymorphisms. Br J Plast Surg 2002;55:283-6.
DOI
ScienceOn
|
22 |
Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003;111:535-43.
DOI
ScienceOn
|
23 |
Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease. Exp Dermatol 2004;13:120-4.
DOI
ScienceOn
|
24 |
Bayat A, Walter JM, Bock O, et al. Genetic susceptibility to keloid disease: mutation screening of the TGFbeta3 gene. Br J Plast Surg 2005;58:914-21.
DOI
ScienceOn
|
25 |
Lu WS, Zhang WY, Li Y, et al. Association of HLA-DRB1 alleles with keloids in Chinese Han individuals. Tissue Antigens 2010;76:276-81.
DOI
ScienceOn
|
26 |
Zhang G, Jiang J, Luo S, et al. Analyses of CDC2L1 gene mutations in keloid tissue. Clin Exp Dermatol 2012;37:277-83.
DOI
ScienceOn
|
27 |
Brown JJ, Ollier WE, Thomson W, et al. Positive association of HLA-DRB1*15 with keloid disease in Caucasians. Int J Immunogenet 2008;35:303-7.
DOI
ScienceOn
|
28 |
Yan L, Lu XY, Wang CM, et al. Association between p53 gene codon 72 polymorphism and keloid in Chinese population. Zhonghua Zheng Xing Wai Ke Za Zhi 2007;23:428-30.
|
29 |
Brown JJ, Ollier W, Arscott G, et al. Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro- Caribbeans. Exp Dermatol 2008;17:610-3.
DOI
ScienceOn
|
30 |
Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93-7.
DOI
ScienceOn
|
31 |
Shih B, Bayat A. Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res. 2012;304:241-9.
DOI
ScienceOn
|
32 |
Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995;376:348-51.
DOI
ScienceOn
|
33 |
Nadeau A, Kinali M, Main M, et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009;73:25-31.
DOI
ScienceOn
|
34 |
Goeminne L. A new probably X-linked inherited syndrome: congenital muscular torticollis, multiple keloids cryptorchidism and renal dysplasia. Acta Genet Med Gemellol (Roma) 1968;17:439-67.
DOI
|
35 |
Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 2012;26:141-52.
DOI
ScienceOn
|
36 |
Chalmers RL. The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring. Int Wound J 2011;8:218-23.
DOI
ScienceOn
|
37 |
Murata H, Zhou L, Ochoa S, et al. TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. J Invest Dermatol 1997;108: 258-62.
DOI
ScienceOn
|
38 |
Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991;97:240-8.
DOI
ScienceOn
|
39 |
Thompson SA, Canady JW, Coberly DM, et al. Effects of TGFbeta2 on collagen synthesis in cultured normal and wounded fetal mouse palates. Cleft Palate Craniofac J 1999; 36:425-33.
DOI
ScienceOn
|
40 |
Bettinger DA, Yager DR, Diegelmann RF, et al. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98:827-33.
DOI
ScienceOn
|
41 |
Messadi DV, Le A, Berg S, et al. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998;3:a16-22.
DOI
|
42 |
Stevens CA, Pouncey J, Knowles D. Adults with Rubinstein- Taybi syndrome. Am J Med Genet A 2011;155A:1680-4.
|
43 |
Siraganian PA, Rubinstein JH, Miller RW. Keloids and neoplasms in the Rubinstein-Taybi syndrome. Med Pediatr Oncol 1989;17:485-91.
|
44 |
Nakashima M, Chung S, Takahashi A, et al. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet 2010;42:768-71.
DOI
ScienceOn
|
45 |
Chung S, Nakashima M, Zembutsu H, et al. Possible involvement of NEDD4 in keloid formation; its critical role in fibro blast proliferation and collagen production. Proc Jpn Acad Ser B Phys Biol Sci 2011;87:563-73.
DOI
ScienceOn
|
46 |
Russell SB, Russell JD, Trupin KM, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010;130:2489-96.
DOI
ScienceOn
|